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The major lipooligosaccharides of the sexually transmitted pathogen Haemophilus ducreyi 35000 have been
previously found to terminate in N-acetyllactosamine and sialyl-N-acetyllactosamine, Neu5Aca233Galb13
4GlcNAc (W. Melaugh, N. J. Phillips, A. A. Campagnari, M. V. Tullius, and B. W. Gibson, Biochemistry 33:
13070–13078, 1994). In this study, mass spectrometry and composition analyses have shown that the lipooligosaccharides from three other H. ducreyi strains also contain N-acetyllactosamine and are highly sialylated ('30
to 50%), although one African strain was found to contain neither of these structural features.
into each well, and the LOS in even-numbered lanes were
preincubated with Newcastle disease virus sialidase (neuraminidase).
For mass spectrometric and composition analyses, 1 to 2 mg
of LOS from each strain was O deacylated by treatment with
anhydrous hydrazine for 20 min at 378C (7). To prepare free
oligosaccharides, LOS was hydrolyzed with 1% acetic acid (2
mg/ml) at 1008C for 2 h and purified by Bio-Gel P-4 chromatography (1.6 by 80 cm, ,400 mesh, 308C) or by high-pressure
liquid chromatography (Bio-Sil TSK-125). To remove phosphate and phosphoesters, '100 mg of oligosaccharide was
treated with cold 48% aqueous HF (10-mg/ml solution) for 16
h at 48C. Details of these procedures can be found elsewhere
(13, 17).
Saccharide composition analysis of oligosaccharides was
performed by using high-pH anion-exchange chromatography
(HPAEC) with pulsed amperometric detection after hydrolysis: 2 M trifluoroacetic acid for 3 h at 1008C. Sialic acid was
determined by treatment with C. perfringens neuraminidase as
described by Yamasaki et al. (23). For strains 35000 and 188,
the weight purity of the LOS samples was determined by assaying for GlcN content. Weighed quantities of LOS ('300
mg) were hydrolyzed in 400 ml of 6 N HCl for 4 h, and the
resulting GlcN was analyzed by HPAEC as previously described (17).
Linkage analysis was performed on purified oligosaccharides
by using a modification of the microscale method of Levery
and Hakomori (10). The resulting partially methylated alditol
acetates were analyzed by gas chromatography-mass spectrometry, using a VG70SE mass spectrometer equipped with a
Hewlett Packard 5890 gas chromatograph and on-column injector (J&W Scientific).
For molecular mass and partial sequence determination,
oligosaccharides were directly analyzed by liquid secondary ion
mass spectrometry (LSIMS) as described elsewhere (17). To
determine LOS heterogeneity and to accurately assign molecular weight and compositions, O-deacylated LOS were analyzed by negative-ion electrospray ionization mass spectrometry (ESI-MS) on a VG/Fison Platform quadrupole mass
spectrometer. O-deacylated LOS were dissolved in water and
then injected (3-ml aliquot, '5 mg) into a stream of H2Oacetonitrile (3:1, vol/vol) containing 1% acetic acid running at
3 to 4 ml/min. Details of these latter methods have been reported in earlier publications (7, 14).
Heterogeneity of H. ducreyi LOS by SDS-PAGE. To assess
LOS heterogeneity and determine the presence of sialic acid,
LOS from five strains of H. ducreyi were subjected to SDS-

The lipooligosaccharides (LOS) of Haemophilus ducreyi, like
LOS of the mucosal pathogens Haemophilus influenzae and
Neisseria gonorrheae, consist of a lipid A moiety embedded in
the outer membrane of the bacterium attached to a variable
oligosaccharide (13, 14, 21). It is thought that LOS is responsible for much of the cytotoxicity of H. ducreyi infection (4), but
the role of the variable oligosaccharide has been difficult to
define. Electrophoretic and mass spectrometric studies of LOS
from numerous H. ducreyi strains have shown them to be highly
heterogeneous (3, 7, 14). Previously, we had determined the
structure of the major oligosaccharide from the LOS of H.
ducreyi 35000 (14) and found it to contain terminal N-acetyllactosamine, i.e., Galb134GlcNAc, which is modified in some
LOS by sialic acid. Given the importance of sialic acid in many
biological systems (19), this acidic sugar is likely to play an
important role in the pathology of H. ducreyi infection.
In this study, we have investigated the presence or absence
of N-acetyllactosamine and sialic acid in the LOS from H.
ducreyi 188, NYC23, 233, and ATCC 33921 as well as one
pyocin variant of strain 188 (2). Since N-acetyllactosamine is
thought to be the acceptor for sialic acid (14), two intriguing
questions were asked: do strains whose LOS terminate in Nacetyllactosamine also contain sialic acid, and do those strains
whose LOS do not contain this disaccharide also lack sialic
acid?
Materials. Glucose (Glc), galactose (Gal), glucosamine
(GlcN), galactosamine, 3-deoxy-D-manno-octulosonic acid
(Kdo), neuraminidase (from Clostridium perfringens), and anhydrous hydrazine were all obtained from Sigma (St. Louis,
Mo.). Aqueous HF (48%) was purchased from Mallinckrodt
(Muskegon, Mich.), and sodium borodeuteride (98% deuterium) was obtained from Aldrich. Acetonitrile, water, and
methanol were obtained from Burdick and Jackson (Muskegon, Mich.). Acetic anhydride was purchased from Supelco
(Bellefonte, Pa.); methyliodide was purchased from Fluka
(Buchs, Switzerland).
Methods. The LOS from H. ducreyi 35000, 188, 233, NYC23,
188-2, and 33921 were isolated by using a modified phenolwater extraction procedure (22). LOS samples were analyzed
by sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis (PAGE) on a 14% polyacrylamide gel as previously
described (14). Approximately 5 to 10 mg of LOS was loaded
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FIG. 1. Composite scan of two SDS-polyacrylamide gels illustrating the LOS patterns from five different strains of H. ducreyi. The LOS in even-numbered lanes were
preincubated with neuraminidase (sialidase), while the LOS in odd-numbered lanes were not. (A) LOS from strains 35000 (lanes 1 and 2), NYC23 (lanes 3 and 4), and
188 (lanes 5 and 6). (B) LOS from strain ATCC 33921 (lanes 1 and 2) and the pyocin-variant strain 188-2 (lanes 3 and 4).

Mass spectrometric and composition analyses of LOS. The
structure of the major oligosaccharide from strain 35000 (14)
and a preliminary set of structures for the LOS of strain 188
and its pyocin variant 188-2 have been previously reported (2).
Data from these studies are included here. With the exception
of the African strain 33921, LSIMS analysis revealed a major
oligosaccharide species for each wild-type strain with a deprotonated molecular ion, (M 2 H)2, at m/z 1,676 (Mr 5 1,677).
When these oligosaccharides were treated with aqueous HF
and reanalyzed by LSIMS, no shift in the mass was observed,
demonstrating the absence of phosphate and phosphoethanolamine (PEA). Some glycosidic bond fragments (sequence ions)
were observed in these LSIMS spectra (data not shown) but
were essentially identical to those reported for the major oligosaccharide of strain 35000 (13). These sequence ions were
seen at m/z 1,514 and 1,311, which corresponded to losses of
hexose (Hex) (2162 Da) and Hex-HexNAc (2365 Da), re-

PAGE analysis before and after treatment with neuraminidase. The composite gel shown in Fig. 1 shows the LOS patterns from the five strains. Figure 1A shows the LOS from H.
ducreyi 35000, NYC23, and 188 that express the epitope defined by monoclonal antibody (MAb) 3F11, which recognizes
the terminal portion of paragloboside, Galb134GlcNAcb13
3Galb134Glc (3). Preincubation of LOS with neuraminidase
caused a downward shift in a prominent LOS band. This electrophoretic shift is consistent with the release of sialic acid.
The gel lanes in Fig. 1B show LOS from H. ducreyi 33921 and
188-2 that do not contain the MAb 3F11 epitope, and preincubation of these LOS with neuraminidase (lanes 2 and 4) does
not cause any shift in the LOS bands. These data suggest that
the wild-type strains 35000, NYC23, and 188 all contain LOS
species with terminal N-acetyllactosamine and sialyl-N-acetyllactosamine, while strain 33921 and the pyocin-variant strain
do not.

TABLE 1. Oligosaccharide composition and methylation analysis
Composition analysisa
(mole ratio relative to glucose)

Strain

35000
NYC23
233
188
188-2
33921
a

Methylation analysisb
(relative peak area)

Glc

Glu

Hep

Heptosec

GlcNH2

t-Gal

3-Gal

6-Glc

t-Hep

2-Hep

3,4-Hep

4-Hep

4-GlcNAc

2.5
2.6
2.0
1.5
0.8
1.3

1.0
1.0
1.0
1.0
1.0
1.0

2.7
2.7
3.3
2.0
2.8
2.9

0.8
0.8
—d
1.1
0.1

1.1
1.1
0.7
0.8

1.0
1.0
1.0
1.0
1.0

1.5
0.7
0.3
0.6

1.7
1.7
1.7
1.8
1.5

0.7
0.5
0.5
0.5
0.3/1.3e
0.5

0.9
0.6
0.5
0.7
1.3
0.7

0.7
0.4
0.2
0.3
0.4
0.5

0.6
0.7
0.6
0.6

1.8
1.0
1.0
1.1

1.0

0.7

4-Glc

t-GlcNAc

1.0

0.9

Kdo was not detected in the hydrolyzed oligosaccharide fraction because of its conversion to anhydroKdo forms during acetic acid hydrolysis of LOS.
Partially methylated alditol acetates are abbreviated according to their substitution pattern as follows: t-Gal is 1,5-di-O-acetyl-2,3,4,6-tetra-O-methylgalactitol, 3-Gal
is 1,3,5-tri-O-acetyl-2,4,6-tri-O-methylgalactitol, etc.
c
This second heptose has been tentatively identified as D-glycero-D-manno-heptose on the basis of earlier data (14), as opposed to the major core heptoses, which
are L-glycero-D-manno-heptoses.
d
The unusual D-glycero-D-manno-heptose was not found in the compositional analysis even though it was clearly present in the methylation analysis data.
e
Two terminal heptoses were found; the ratio stated is the unusual D-glycero-D-manno-heptose to the expected terminal core L-glycero-D-manno-heptose.
b
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FIG. 2. Partial negative-ion electrospray ionization mass spectrum of O-deacylated LOS from H. ducreyi 35000 (A) and 233 (B) before (top) and after (bottom)
neuraminidase treatment. LOS-A to LOS-F correspond to the same m/z peaks seen for both strains. Shaded peaks at m/z 1,000 and 1,041 correspond to LOS species
thought to contain sialic acid which disappear after neuraminidase treatment (bottom spectra). See Table 4 for the assignments of LOS compositions.

spectively. The oligosaccharides from strains 35000 and 188
showed additional sequence ions corresponding to further
losses of Hex-HexNAc-Hex (m/z 1,149) and Hex-HexNAcHex-Hep (m/z 957) and, from a second branch, losses of Lglycero-D-manno-heptose (Hep) (m/z 1,484) and Hep-Hep (m/z
1,292).
The LSIMS spectrum of the oligosaccharide from the LOS
of the African strain 33921 had an (M 2 H)2 at m/z 1,322 (Mr
5 1,323), representing a much smaller oligosaccharide than in
the other strains. There were also sequence ions present corresponding to losses of HexNAc (m/z 1,119), HexNAc-Hex
(m/z 957), and HexNAc-Hex-Hex (m/z 795), indicative of a
trisaccharide branch off a Hep3anhydroKdo core, Mr (calculated) 5 1,323. The LSIMS spectrum of the oligosaccharide from
the pyocin-variant strain 188-2 also showed a smaller oligosaccharide with an (M 2 H)2 at m/z 1,434. Treatment of this
oligosaccharide with HF to remove phosphoesters shifted the
mass to m/z 1,311, indicating that PEA (Dm 5 123 Da) had
been removed. Previous sequence analysis (2) had suggested
this oligosaccharide contained a Hex-Hep-Hex trisaccharide

off a Hep3(PEA)anhydroKdo core, which is consistent with the
current LSIMS data.
Composition analysis of the oligosaccharides from each
strain by using HPEAC identified Glc, Gal, GlcN, and Hep in
the molar ratios shown in Table 1. In the HPAEC profile of
strains 35000, NYC23, 188, and 188-2, a peak was observed for
D-glycero-D-manno-heptose (13). Free Kdo was not seen in the
composition analysis.
To identify the monosaccharides and their linkages, linkage
analysis of the major oligosaccharide from each strain was
performed. For strains 35000, NYC23, 233, and 188, eight
major sugars eluted in the following order: terminal Gal,
3-Gal, 6-Glc, terminal Hep, 4-Hep, 2-Hep, 3,4-Hep, and 4GlcNAc (Table 1). Methylation analysis of strain 188-2 shows
that this pyocin variant lacks the 3-linked Gal and 4-linked
GlcNAc seen in the wild-type strains. Strain 33921 has the
same inner core sugars as the other strains and an outer core
branch consisting of 4-linked Glc, 3-linked Gal, and a terminal
GlcNAc.
Given the similarities in the LSIMS, compositional, and
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FIG. 2—Continued.

linkage data for strains 35000, 233, 188, and NYC23, it appears
that all four strains contain an oligosaccharide identical (or
highly similar) to that reported for strain 35000 (see below)
(14). The oligosaccharide of strain 188-2, which is a pyocin
variant of strain 188, lacks the terminal N-acetyllactosamine,
Galb134GlcNAc, present in the structure shown below and
contains a PEA most likely located in the core heptose region
(2):
Galb134GlcNAcb133Galb134Hepa136Glcb134Hepa13anhydroKdo
3
1
Hepa132Hepa1

The Kenyan strain 33921, however, appears to possess the
same core (Hep3anhydroKdo) but differs in the carbohydrate branch by containing only three sugars, a 4-linked Glc,
a 3-linked Gal, and a terminal GlcNAc. This strain, therefore, lacks the terminal N-acetyllactosamine and the
4-linked Hep evident in the other wild-type strains. On the
basis of immunochemical data that show strong binding to
MAb 4C8 specific for N. gonorrhoeae 1291a LOS (9), the
terminal trisaccharide in this strain is most probably
GlcNAcb133Galb134Glcb1.

Molecular weight analysis of LOS by ESI-MS. To determine
what additional LOS structures are present and what relationship they bear to the major oligosaccharides, ESI-MS was used
to assess LOS heterogeneity. LOS were first converted to
water-soluble forms by O deacylation with hydrazine, which
forms primarily doubly and/or triply charged deprotonated
species, (M 2 2H)2- and (M 2 3H)3-, under ESI-MS conditions, from which the mass (molecular weight) can be readily
assigned (7).
The top part of Fig. 2A shows the ESI-MS spectrum of Odeacylated LOS from strain 35000 before neuraminidase treatment. The most abundant ion is the triply charged species (M
2 3H)3- at m/z 902.8, which corresponds to an average Mr of
2711.4 (LOS-B). The molecular weight of this O-deacylated
LOS species is consistent with the attachment of an O-deacylated lipid A moiety to the major oligosaccharide terminating
in N-acetyllactosamine (but still containing the phosphate on
the Kdo) as previously described (13, 14):
Galb134GlcNAcb133Galb134Hepa136Glcb134Hepa13Kdo(P)-O-deacyl-lipid A
3
1
Hep1a32Hepa1
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TABLE 2. ESI-MS analyses of O-deacylated LOS from H. ducreyi 35000, 188, 233, and NYC23

Mr calculated

1,829.7
1,952.7
1,991.8
2,114.8
2,184.0
2,307.0
2,346.1
2,469.2
2,549.3
2,672.4
2,711.5
2,834.5
2,914.7
3,002.7
3,125.7

Mr observed (relative % abundance)a,b
35000

2,548.8 (25)
2,711.4 (100)
2,834.7 (27)
2,913.9 (18)
3,003.0 (66)
3,127.2 (20)

188

1,830.3 (13)
1,953.6 (37)
1,991.1 (5)
2,115.0 (4)
2,181.6 (2)
2,305.8 (18)
2,346.0 (26)
2,469.0 (13)
2,549.1 (41)
2,673.0 (49)
2,713.8 (46)
2,833.8 (98)
3,002.4 (46)
3,127.8 (100)

Proposed compositionc

233

NYC23

2,711.7 (92)
2,834.7 (41)

2,342.7 (10)
2,470.2 (9)
2,548.2 (60)
2,670.0 (44)
2,711.4 (58)
2,835.3 (57)

3,003.3 (100)
3,126.0 (47)

3,001.5 (72)
3,125.7 (100)

2,549.1 (24)

Hep3 Kdo(P) lipid Ad
Hep3 PEA Kdo(P) lipid A
Hex Hep3 Kdo(P) lipid A
Hex Hep3 PEA Kdo(P) lipid A
Hex Hep4 Kdo(P) lipid A
Hex Hep4 PEA Kdo(P) lipid A
Hex2 Hep4 Kdo(P) lipid A
Hex2 Hep4 PEA Kdo(P) lipid A
Hex2 HexNAc Hep4 Kdo(P) lipid A
Hex2 Hep4 PEA HexNAc Kdo(P) lipid A
(Hex-HexNAc) Hex2 Hep4 Kdo(P) lipid A
(Hex-HexNAc)Hex2 Hep4 PEA Kdo(P) lipid A
Hex3 HexNAc2 Hep4 Kdo(P) lipid A
(Neu5Ac-Hex-HexNAc)Hex2 Hep4 Kdo(P) lipid A
(Neu5Ac-Hex-HexNAc)Hex2 Hep4 PEA Kdo(P) lipid A

a

Reported as average mass value based on the triply charged ions.
Peaks originating from loss of water have been omitted for purposes of simplicity.
c
Sugars in parentheses are likely present as N 5 acetyllactosamine and N 5 acetylsialyllactosamine (see text).
d
After O deacylation, the lipid A moiety is converted into diphosphoryl diacyl lipid A containing two N-linked b-hydroxymyristic acid chains with an average Mr of
953.0089.
b

The triply charged ions at m/z 848.6, 943.9, and 970.3 represent
major oligosaccharide species which are either truncated
(2Hex, LOS-A) or extended and/or phosphorylated LOS glycoforms (1PEA, LOS-C; 1HexNAc, LOS-D; 1Hex-HexNAc,
LOS-G) of the major LOS-B species. The average Mr’s and
compositions of these species are listed in Table 2. However,
three of these peaks at m/z 1,000.0, 1,041.4, and 1,500.3 correspond to two additional LOS analogs whose masses suggest the
addition of sialic acid (LOS-E, Mr 5 3,003) and sialic acid plus
PEA (LOS-F, Mr 5 3,127). In support of these latter LOS
assignments, the shaded peaks representing the triply and doubly charged ions of these two sialylated glycoforms disappear
after neuraminidase treatment (Fig. 2A, bottom).
The spectrum of O-deacylated LOS from H. ducreyi 233
before neuraminidase treatment is similar to that of strain
35000 except that the LOS-D glycoform is absent and the base
peak is now the sialylated analog of the major species (Fig. 2B,
top). Peaks representing triply charged molecular ions of the
sialylated LOS analogs at m/z 1,000.1 and 1,041.0 are again
shaded and, like the sialylated LOS glycoforms in strain 35000,
are quantitatively removed after treatment with neuraminidase
(Fig. 2B, bottom).
The ESI-MS spectra of O-deacylated LOS from H. ducreyi
188 (2) and NYC23 were found to be similar to those of strains

35000 and 233 with the difference that the latter strains are
more heterogeneous and exhibit a greater degree of phosphorylation. The relative abundances and composition assignments
are summarized in Table 2.
The ESI-MS spectrum of O-deacylated LOS from H. ducreyi
33921 (spectrum not shown; see Table 3) is markedly unlike
those of the previous wild-type strains. The major ion in this
spectrum is the triply charged ion at m/z 825.8, corresponding
to a species containing a HexNAc-Hex2 oligosaccharide branch
off a Hep3(PEA)Kdo(P)-lipid A core (Mr 5 2,480). A peak at
m/z 784.8 was assigned as a triply charged LOS missing the
PEA, and the peak at m/z 866.6 as a triply charged LOS
containing an extra PEA. There is no evidence for the presence
of sialic acid or N-acetyllactosamine.
The spectrum of O-deacylated LOS from H. ducreyi 188-2
was previously found to contain a triply charged base peak at
m/z 822.3 (Mr 5 2,469.5), a truncated version of the same
major structure seen in the other strains lacking N-acetyllactosamine. No sialylation of the major oligosaccharide species
was evident (2), and no change was observed after neuraminidase treatment. The observed masses and proposed compositions of the LOS glycoforms for this pyocin-variant strain and
for strain ATCC 33921 are listed in Table 3.
Sialic acid content. To independently identify the presence

TABLE 3. ESI-MS analyses of O-deacylated LOS from H. ducreyi ATCC 33921 and 188-2
Mra
Calculated

Relative %
abundance

Proposed composition

Observed

2,276.8
2,307.3
2,469.5
2,592.0
2,712.7
2,357.4
2,480.4
2,602.8

2,277.0
2,307.0
2,469.2
2,592.2
2,711.4
2,357.1
2,480.2
2,603.3

10
29
100
10
4
72
100
49

Hex2 Hep3 PEA Kdo(P) lipid Ab
Hex Hep4 PEA Kdo(P) lipid A
Hex2 Hep4 PEA Kdo(P) lipid A
Hex2 Hep4 PEA2 Kdo(P) lipid A
Hex3 HexNAc Hep4 Kdo(P) lipid A
Hex2 HexNAc Hep3 Kdo(P) lipid A
Hex2 HexNAc Hep3 PEA Kdo(P) lipid A
Hex2 HexNAc Hep3 PEA2 Kdo(P) lipid A

Strain

188-2

33921

a

Reported as average mass value based on the triply charged ions.
After O deacylation, the lipid A moiety is converted into diphosphoryl diacyl lipid A containing two N-linked b-hydroxymyristic acid chains with an average Mr of
953.0089.
b
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FIG. 3. High-pH anion-exchange chromatogram of precipitated LOS fraction of H. ducreyi 35000 incubated with neuraminidase (A) and heat-inactivated
neuraminidase (B). Chromatograms for other strains found to contain sialic acid
(233, 188, and NYC23) were similar.

of sialic acid in the LOS of these strains, LOS samples were
treated with neuraminidase and the released sialic acid was
measured by HPAEC. Figure 3 shows the chromatogram of
the LOS from H. ducreyi 35000 incubated with neuraminidase
and heat-inactivated neuraminidase. Sialyllactose was used as
a control, and sialic acid eluted at 7.8 min. The chromatograms
of the LOS from strains 233, NYC23, and 188 looked similar,
while those of strains 188-2 and 33921 contained no detectable
levels of sialic acid. Since we would like to know the relative
molar proportions of LOS species containing sialic acid (i.e.,
mole percent of LOS), the purity of the LOS was independently determined by assessing glucosamine content in two
LOS preparations in which sufficient materials were available.
We assumed that the best estimate of the weight purity of LOS
is 3 mol of glucosamine (2 mol from the lipid A and 1 mol from
the oligosaccharide) per mol of LOS. Once the weight purities
were determined, the sialic acid content was assigned as 21
mol% for strain 35000 and 54 mol% for strain 188 (Table 4).
These values were in rough agreement with those estimated
from relative peak abundance of sialylated LOS in the ESI-MS
spectra. The LOS of strains NYC23 and 233 also contained
sialic acid at greater than 10 mol% (39 to 42% by the ESI-MS
estimates), but insufficient material was available to accurately
assess weight or purity.
Discussion. Data obtained on the oligosaccharides of strains
233, 188, and NYC23 suggest that the major LOS glycoforms
containing N-acetyllactosamine and sialyl-N-acetyllactosamine, as
previously determined for strain 35000 (14), are also present in
these wild-type strains. MAb 3F11, which recognizes the terminal region of paragloboside, also binds strongly to the LOS

TABLE 4. Sialic acid content of LOS from various
strains of H. ducreyi
Bacterial strain

Mol% sialic acid

Sialic acid content (%) calculated
from ESI-MS dataa

35000
188
188-2
233c
NYC23c
33921

21
54
NDb
1
1
ND

31
47
0
39
42
0

a
Calculated by taking the ratio of the sum of the heights of the sialylated
peaks to the sum of the heights of all the peaks in the electrospray spectra.
b
ND, none detected.
c
Presence of sialic acid was verified in the LOS of this strain. However,
although the sialic acid content appeared to be greater than 10 mol% in each
case, the extent of sialylation could not be reproducibly quantified because of
small sample amount.
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of these wild-type strains. In contrast, the African strain ATCC
33921 and the variant strain 188-2 have lost the terminal LOS
epitope defined by MAb 3F11 (2) as well as the ability to add
sialic acid to their LOS. The presence of sialic acid in the LOS
of all but one wild-type strain, suggests that N-acetyllactosamine is the acceptor for sialic acid, as does the fact that the
strains that do not contain this disaccharide (188-2 and 33921)
show no evidence of sialylation. Although the precise roles of
LOS containing N-acetyllactosamine and sialyl-N-acetyllactosamine are not known, adherence of the African strain 33921
to cultured human keratinocytes is greatly diminished compared with adherence of all other H. ducreyi wild-type strains
tested (1a).
Studies of Neisseria spp. have shown that sialyltransferases
are primarily limited to pathogenic species, such as N. gonorrhoeae and N. meningitidis (11). In N. meningitidis, the addition
of sialic acid to LOS has been shown to be linked, like that in
H. ducreyi, to terminal N-acetyllactosamine (23). Moreover,
the sialylation of neisserial LOS can result in the conversion
from serum sensitivity to serum resistance in some strains (15)
and a marked decrease in susceptibility to killing by human
neutrophils (6, 18). There is mounting evidence that sialic acid
can prevent the recognition of antigenic sites by components of
the immune defense system (19). It may be that large, negatively charged sialic acid residues on the branched oligosaccharide chains of H. ducreyi LOS mask antigenic recognition sites
on the surface of the bacterial cell, enabling the organism to
escape the host defenses. The negative charge of sialic acid can
have a significant influence on conformations of complex carbohydrates, as reduction of the carboxyl groups in the terminal
sialic acids in Streptococcus and Neisseria capsular polysaccharides drastically alters their immunological properties (8). Although it is not yet known how or whether sialic acid biosynthesis is regulated in vivo, the mole percent values for LOS
species containing sialic acid are very similar ('30 to 50 mol%
in four of five strains) and considerably higher than that reported for H. influenzae LOS (12, 16). Indeed, the relatively
high level of sialic acid present on the terminal structures of H.
ducreyi LOS is reminiscent of the group B streptococcal polysaccharides, for which high levels of sialic acid were found to
be important in defining immunodeterminants and preventing
activation of the alternative complement pathway (5, 20).
Sialylation of LOS could also modulate the cytotoxicity of
the lipid A. We have recently constructed an assay using cultured human keratinocytes for assessing LOS adhesion (1) and
have now modified this procedure to obtain preliminary results
on LOS cytotoxicity. These preliminary data have suggested
that the LOS from the pyocin-variant strain 188-2, which lacks
both N-acetyllactosamine and sialic acid, is less toxic than
strains 188 and 35000. Given the complexities of LOS structures, additional biological studies will be needed to determine
the precise roles of the LOS glycoforms containing N-acetyllactosamine and sialic acid in the pathogenic mechanisms of H.
ducreyi.
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